Opioid analgesics (formerly opiates - substances derived from opium, or narcotics - substances that induce sleep ) have a very strong analgesic effect. They suppress visceral pain, suppress the psychological component and the emotional reaction to pain. They act centrally, supraspinally. They have an analgesic and antitussive effect. The main representative is morphine. A person can easily become addicted to them.
Structure[edit | edit source]
Depending on the structure, we distinguish between 2 groups of opioids :
- derived from the morphine molecule found in opium, the dried sap of poppy seeds
- synthetic (derived from the phenylpiperazine molecule) − pethidine, fentanyl, megaphone
Human body is capable of producing endogenous opioids, which include endorphins, enkephalins, dynorphin and endomorphins. They are synthesized in nervous tissue from precursors :
- pre-POMC (pre-pro-opiomelanocortin) − precursor to β-endorphin, ACTH and MSH (melanocyte stimulating hormone)
- pre-pro-enkephalin A - precursor to met-enkephalin and leu-enkephalin
- pre-pro-enkephalin B − precursor to dynorphin and neo-endorphin
Another opioid peptide is nociceptin, which is similar to dynorphin and affects the perception of pain, although it does not interact with any of the known opioid receptors.
Pharmacodynamics[edit | edit source]
Opioids act on 3 types of opioid receptors: μ, κ and δ. According to the affinity of individual opioids to these receptors, we can divide them as follows:
- agonists − morphine, pethidine, oxycodone, etc.;
- partial agonists − buprenorphine;
- antagonists − naloxone.
Effects on the CNS:
- calming down – removing tension and fear;
- euphoria – inner bliss – leads to addiction;
- dysphoria – κ (pentazine) bad moods, nightmares – pentazocine (psychotomimetic effects);
- drowsiness, delirium - "downers" - premedication before surgery. In case of overdose, it can lead to unconsciousness (respiratory depression, anesthesia);
- respiration - they reduce the sensitivity of the respiratory center to CO2 (typically fentanyl), which can lead to respiratory depression - monitoring with an oximeter;
- antitussive - therapeutically codeine, (due to potential risks of opioids, antitussives without a central effect are used - butamirate, dropypizin).
- nausea/vomiting - a frequent side effect is vomiting due to the effect on the area in the medulla oblongata - it disappears after repeated administration or with the addition of an antiemetic;
- miosis – is also a marker of opioid intoxication (except for pethidine);
- neuroendocrine – increased secretion of ADH, PRL, STH, decreased secretion of FSH, LH.
Peripheral effects of OA:
- GI tract – increased smooth muscle tone, slowing down the intestinal passage, closing the sphincters (causing spastic constipation);
- Cardiovascular system – in the case of a myocardial infarction, it is necessary to distinguish between opioids, as morphine causes histamine release, which leads to hypotension. Fentanyl is a better option (it has better hemodynamics);
- reduction of uterine tone and uterine motility - slowing down labor;
- reduction of epithelial cilia movement (tubes, bronchi);
- bronchoconstriction - due to histamine release;
- muscle rigidity – fentanyl – ICU with ventilation;
- passing into breast milk (infants cannot metabolize OA)
- passing through the placental barrier - blue baby (respiration supression).
Principles of administration[edit | edit source]
- An intravenous form is indicated for acute pain, an oral form for chronic pain.
- Titration administration starting from the lowest doses.
- Initiating treatment means testing the opioid for a specific pain.
- Administration of antiemetics in the first days, constipation treatment and laxatives.
- There is no maximum dose for cancer pain. For chronic non-cancer pain, doses higher than 180-200 mg of morphine have not proven effective.
- In case of developing side effects, or if the efficacy of the treatment decreases, it is reccomended to switch to another opioid.
Side effects[edit | edit source]
- respiratory depression - the most feared complication;
- nausea, vomiting;
- increased pressure in the bile ducts;
- urine retention;
- increase in tolerance - need to increase the dose in order to maintain initial effect.
Representatives[edit | edit source]
- Weak opioids - a ceiling effect may apply (further dose increasing does not lead to an increase in the effect)
- Strong opioids - for severe intractable pain
- Methadone − only as a substitution treatment for psychological addiction. 
Recalculation of dose and calculation of the next dose[edit | edit source]
Links[edit | edit source]
Related articles[edit | edit source]
External links[edit | edit source]
References[edit | edit source]
- HYNIE, Sixtus. Farmakologie v kostce. 2. edition. Praha : Triton, 2001. ISBN 80-7254-181-1.
- Zdraví E15. Opioidní analgetika [online]. Mladá fronta a. s., ©2006. [cit. 2014-03-03]. <https://web.archive.org/web/20160331222721/http://zdravi.e15.cz/clanek/postgradualni-medicina/opioidni-analgetika-264351>.
- ↑ a b c d e f LEJČKO, Jan. Přehled opioidních analgetik. Prakt. lékáren [online]. 2009, vol. 4, p. 172-175, Available from <http://www.praktickelekarenstvi.cz/pdfs/lek/2009/04/05.pdf>. ISSN 1803-5329.
- ↑ HERDEGEN, Thomas. Kurzlehrbuch Pharmakologie und Toxikologie : 328 Tabellen. 2.. edition. Thieme, 2010. pp. 253. ISBN 9783131422927.
- ↑ KOLEKTIV AUTORŮ POSTGRADUÁLNÍ MEDICÍNA,. Opioidní analgetika. Postgraduální medicína [online]. 2006, vol. 4, p. 395, Available from <https://web.archive.org/web/20160331222721/http://zdravi.e15.cz/clanek/postgradualni-medicina/opioidni-analgetika-264351>. ISSN 1212-4184.